178 related articles for article (PubMed ID: 34122724)
1. FOXO3a Protects against Kidney Injury in Type II Diabetic Nephropathy by Promoting Sirt6 Expression and Inhibiting Smad3 Acetylation.
Wang X; Ji T; Li X; Qu X; Bai S
Oxid Med Cell Longev; 2021; 2021():5565761. PubMed ID: 34122724
[TBL] [Abstract][Full Text] [Related]
2. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
[TBL] [Abstract][Full Text] [Related]
3. LRNA9884, a Novel Smad3-Dependent Long Noncoding RNA, Promotes Diabetic Kidney Injury in
Zhang YY; Tang PM; Tang PC; Xiao J; Huang XR; Yu C; Ma RCW; Lan HY
Diabetes; 2019 Jul; 68(7):1485-1498. PubMed ID: 31048367
[TBL] [Abstract][Full Text] [Related]
4. P2Y2R contributes to the development of diabetic nephropathy by inhibiting autophagy response.
Dusabimana T; Kim SR; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Mol Metab; 2020 Dec; 42():101089. PubMed ID: 32987187
[TBL] [Abstract][Full Text] [Related]
5. AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice.
Chung JY; Tang PM; Chan MK; Wang L; Huang XR; To KF; Ma RC; Lan HY
Int J Biol Sci; 2022; 18(14):5489-5502. PubMed ID: 36147472
[TBL] [Abstract][Full Text] [Related]
6. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in
Sun SF; Tang PMK; Feng M; Xiao J; Huang XR; Li P; Ma RCW; Lan HY
Diabetes; 2018 Apr; 67(4):731-744. PubMed ID: 29222368
[TBL] [Abstract][Full Text] [Related]
7. The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression.
Cai J; Liu Z; Huang X; Shu S; Hu X; Zheng M; Tang C; Liu Y; Chen G; Sun L; Liu H; Liu F; Cheng J; Dong Z
Kidney Int; 2020 Jan; 97(1):106-118. PubMed ID: 31787254
[TBL] [Abstract][Full Text] [Related]
8. Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.
Zhao TT; Zhang HJ; Lu XG; Huang XR; Zhang WK; Wang H; Lan HY; Li P
PLoS One; 2014; 9(3):e90807. PubMed ID: 24646636
[TBL] [Abstract][Full Text] [Related]
9. Diosgenin protects against podocyte injury in early phase of diabetic nephropathy through regulating SIRT6.
Wang Z; Wu Q; Wang H; Gao Y; Nie K; Tang Y; Su H; Hu M; Gong J; Fang K; Dong H
Phytomedicine; 2022 Sep; 104():154276. PubMed ID: 35728388
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy.
Xu BH; Sheng J; You YK; Huang XR; Ma RCW; Wang Q; Lan HY
Metabolism; 2020 Feb; 103():154013. PubMed ID: 31734275
[TBL] [Abstract][Full Text] [Related]
11. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
12. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
13. Treatment for type 2 diabetes and diabetic nephropathy by targeting Smad3 signaling.
He H; Wang H; Chen X; Zhong Y; Huang XR; Ma RC; Wang C; Lan HY
Int J Biol Sci; 2024; 20(1):200-217. PubMed ID: 38164169
[TBL] [Abstract][Full Text] [Related]
14. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneous Nuclear Ribonucleoprotein F Stimulates Sirtuin-1 Gene Expression and Attenuates Nephropathy Progression in Diabetic Mice.
Lo CS; Shi Y; Chenier I; Ghosh A; Wu CH; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
Diabetes; 2017 Jul; 66(7):1964-1978. PubMed ID: 28424160
[TBL] [Abstract][Full Text] [Related]
16. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
[TBL] [Abstract][Full Text] [Related]
17. SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.
Zhong X; Huang M; Kim HG; Zhang Y; Chowdhury K; Cai W; Saxena R; Schwabe RF; Liangpunsakul S; Dong XC
Cell Mol Gastroenterol Hepatol; 2020; 10(2):341-364. PubMed ID: 32305562
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Sirt6 promotes M2 macrophage transformation, alleviating renal injury in diabetic nephropathy.
Ji L; Chen Y; Wang H; Zhang W; He L; Wu J; Liu Y
Int J Oncol; 2019 Jul; 55(1):103-115. PubMed ID: 31115579
[TBL] [Abstract][Full Text] [Related]
19. Effects of Bone Marrow Mesenchymal Stem Cells on Plasminogen Activator Inhibitor-1 and Renal Fibrosis in Rats with Diabetic Nephropathy.
Lang H; Dai C
Arch Med Res; 2016 Feb; 47(2):71-7. PubMed ID: 27018336
[TBL] [Abstract][Full Text] [Related]
20. SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy.
Zhang Y; Nie L; Xu K; Fu Y; Zhong J; Gu K; Zhang L
Theranostics; 2019; 9(8):2380-2394. PubMed ID: 31149050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
